table of content
1 Study Coverage
1.1 Prostate Cancer Drugs Product Introduction
1.2 Global Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.3 United States Prostate Cancer Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Prostate Cancer Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Prostate Cancer Drugs Sales in Volume for the Year 2017-2028
1.4 Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Prostate Cancer Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Prostate Cancer Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Prostate Cancer Drugs Market Dynamics
1.5.1 Prostate Cancer Drugs Industry Trends
1.5.2 Prostate Cancer Drugs Market Drivers
1.5.3 Prostate Cancer Drugs Market Challenges
1.5.4 Prostate Cancer Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Prostate Cancer Drugs Market Segment by Type
2.1.1 Hormonal Therapy
2.1.2 Chemotherapy
2.1.3 Immunotherapy
2.1.4 Targeted Therapy
2.2 Global Prostate Cancer Drugs Market Size by Type
2.2.1 Global Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Prostate Cancer Drugs Market Size by Type
2.3.1 United States Prostate Cancer Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Prostate Cancer Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Prostate Cancer Drugs Market Segment by Application
3.1.1 Clinics
3.1.2 Hospitals
3.1.3 Others
3.2 Global Prostate Cancer Drugs Market Size by Application
3.2.1 Global Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Prostate Cancer Drugs Market Size by Application
3.3.1 United States Prostate Cancer Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Prostate Cancer Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Prostate Cancer Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Prostate Cancer Drugs Competitor Landscape by Company
4.1 Global Prostate Cancer Drugs Market Size by Company
4.1.1 Top Global Prostate Cancer Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Prostate Cancer Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Prostate Cancer Drugs Price by Manufacturer (2017-2022)
4.2 Global Prostate Cancer Drugs Concentration Ratio (CR)
4.2.1 Prostate Cancer Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Prostate Cancer Drugs in 2021
4.2.3 Global Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Prostate Cancer Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Prostate Cancer Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Prostate Cancer Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Drugs Market Size by Company
4.5.1 Top Prostate Cancer Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Prostate Cancer Drugs Sales by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Drugs Market Size by Region
5.1 Global Prostate Cancer Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Prostate Cancer Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Prostate Cancer Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Prostate Cancer Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Prostate Cancer Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Prostate Cancer Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Corporation Information
7.1.2 AbbVie Description and Business Overview
7.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 AbbVie Prostate Cancer Drugs Products Offered
7.1.5 AbbVie Recent Development
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporation Information
7.2.2 Astellas Pharma Description and Business Overview
7.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Astellas Pharma Prostate Cancer Drugs Products Offered
7.2.5 Astellas Pharma Recent Development
7.3 Astra Zeneca
7.3.1 Astra Zeneca Corporation Information
7.3.2 Astra Zeneca Description and Business Overview
7.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Astra Zeneca Prostate Cancer Drugs Products Offered
7.3.5 Astra Zeneca Recent Development
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporation Information
7.4.2 Johnson & Johnson Description and Business Overview
7.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Johnson & Johnson Prostate Cancer Drugs Products Offered
7.4.5 Johnson & Johnson Recent Development
7.5 Sanofi
7.5.1 Sanofi Corporation Information
7.5.2 Sanofi Description and Business Overview
7.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Sanofi Prostate Cancer Drugs Products Offered
7.5.5 Sanofi Recent Development
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporation Information
7.6.2 GlaxoSmithKline Description and Business Overview
7.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 GlaxoSmithKline Prostate Cancer Drugs Products Offered
7.6.5 GlaxoSmithKline Recent Development
7.7 Merck Group
7.7.1 Merck Group Corporation Information
7.7.2 Merck Group Description and Business Overview
7.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Merck Group Prostate Cancer Drugs Products Offered
7.7.5 Merck Group Recent Development
7.8 Novartis
7.8.1 Novartis Corporation Information
7.8.2 Novartis Description and Business Overview
7.8.3 Novartis Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Novartis Prostate Cancer Drugs Products Offered
7.8.5 Novartis Recent Development
7.9 Amgen
7.9.1 Amgen Corporation Information
7.9.2 Amgen Description and Business Overview
7.9.3 Amgen Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Amgen Prostate Cancer Drugs Products Offered
7.9.5 Amgen Recent Development
7.10 Bayer HealthCare
7.10.1 Bayer HealthCare Corporation Information
7.10.2 Bayer HealthCare Description and Business Overview
7.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Bayer HealthCare Prostate Cancer Drugs Products Offered
7.10.5 Bayer HealthCare Recent Development
7.11 Ferring Pharmaceutical
7.11.1 Ferring Pharmaceutical Corporation Information
7.11.2 Ferring Pharmaceutical Description and Business Overview
7.11.3 Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ferring Pharmaceutical Prostate Cancer Drugs Products Offered
7.11.5 Ferring Pharmaceutical Recent Development
7.12 Janssen Pharmaceuticals
7.12.1 Janssen Pharmaceuticals Corporation Information
7.12.2 Janssen Pharmaceuticals Description and Business Overview
7.12.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Janssen Pharmaceuticals Products Offered
7.12.5 Janssen Pharmaceuticals Recent Development
7.13 Endo Pharmaceuticals
7.13.1 Endo Pharmaceuticals Corporation Information
7.13.2 Endo Pharmaceuticals Description and Business Overview
7.13.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Endo Pharmaceuticals Products Offered
7.13.5 Endo Pharmaceuticals Recent Development
7.14 BMS
7.14.1 BMS Corporation Information
7.14.2 BMS Description and Business Overview
7.14.3 BMS Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 BMS Products Offered
7.14.5 BMS Recent Development
7.15 Takeda Pharmaceuticals
7.15.1 Takeda Pharmaceuticals Corporation Information
7.15.2 Takeda Pharmaceuticals Description and Business Overview
7.15.3 Takeda Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Takeda Pharmaceuticals Products Offered
7.15.5 Takeda Pharmaceuticals Recent Development
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Corporation Information
7.16.2 Northwest Biotherapeutics Description and Business Overview
7.16.3 Northwest Biotherapeutics Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Northwest Biotherapeutics Products Offered
7.16.5 Northwest Biotherapeutics Recent Development
7.17 Teva Pharmaceutical
7.17.1 Teva Pharmaceutical Corporation Information
7.17.2 Teva Pharmaceutical Description and Business Overview
7.17.3 Teva Pharmaceutical Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Teva Pharmaceutical Products Offered
7.17.5 Teva Pharmaceutical Recent Development
7.18 Boehringer Ingelheim
7.18.1 Boehringer Ingelheim Corporation Information
7.18.2 Boehringer Ingelheim Description and Business Overview
7.18.3 Boehringer Ingelheim Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Boehringer Ingelheim Products Offered
7.18.5 Boehringer Ingelheim Recent Development
7.19 Foresee Pharmaceuticals
7.19.1 Foresee Pharmaceuticals Corporation Information
7.19.2 Foresee Pharmaceuticals Description and Business Overview
7.19.3 Foresee Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Foresee Pharmaceuticals Products Offered
7.19.5 Foresee Pharmaceuticals Recent Development
7.20 Tokai Pharmaceuticals
7.20.1 Tokai Pharmaceuticals Corporation Information
7.20.2 Tokai Pharmaceuticals Description and Business Overview
7.20.3 Tokai Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Tokai Pharmaceuticals Products Offered
7.20.5 Tokai Pharmaceuticals Recent Development
7.21 Spectrum Pharmaceuticals
7.21.1 Spectrum Pharmaceuticals Corporation Information
7.21.2 Spectrum Pharmaceuticals Description and Business Overview
7.21.3 Spectrum Pharmaceuticals Prostate Cancer Drugs Sales, Revenue and Gross Margin (2017-2022)
7.21.4 Spectrum Pharmaceuticals Products Offered
7.21.5 Spectrum Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Prostate Cancer Drugs Industry Chain Analysis
8.2 Prostate Cancer Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Prostate Cancer Drugs Distributors
8.3 Prostate Cancer Drugs Production Mode & Process
8.4 Prostate Cancer Drugs Sales and Marketing
8.4.1 Prostate Cancer Drugs Sales Channels
8.4.2 Prostate Cancer Drugs Distributors
8.5 Prostate Cancer Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
